While, the reported anti-hyperglycemic and antioxidant effects of escitalopram, in the present study, could be responsible for the decreased p53 content as hyperglycemia-induced oxidative DNA damage is a known stimulator for p53 upregulation (Cai and Kang, 2003; Liu et al., 2009). This evidence concerns the gene TP53 and Hyperglycemia.